Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commercialization admin April 4, 2018 PR You Might Also Like New VC fund to set sights on Israeli tech for eye diseases April 9, 2018 Israel’s life sciences firms said to raise record $1.5 billion in 2018 May 16, 2019 UK Turns To Israel For More Medtech Innovation April 25, 2019
